Status:

UNKNOWN

Management and Outcomes of Anti-thrombotic Medication Use in Thrombocytopenia

Lead Sponsor:

Maastricht University Medical Center

Conditions:

Hematologic Neoplasms

Thrombocytopenia

Eligibility:

All Genders

18+ years

Brief Summary

Background: Antithrombotic therapy in the context of treatment related thrombocytopenia (i.e. low levels of platelets) is not uncommon. Guidelines are based upon a paucity of retrospective data and fo...

Detailed Description

* Thrombocyte-level cohorts Patients will be divided into two groups based on the platelet level at study index . 1. Thrombocytopenic Cohort: Patients with morning platelet count below 50\*109/L at...

Eligibility Criteria

Inclusion

  • Any hematological malignancy with or without active treatment (including autologous or allogeneic stem cell transplantation), irrespective of the treatment line and disease status.
  • Disease-related and/or current/predicted treatment-related thrombocytopenia (\<50 X 109/L) of any duration.
  • Current antiplatelet and/or anticoagulant treatment of any duration and for any indication. This treatment may have been started before or after diagnosis of the hematological malignancy and thrombocytopenia.
  • "Current" refers to the time when the current thrombocytopenia, or risk thereof (i.e. "predicted"), was first identified (even if the treatment is subsequently stopped)

Exclusion

  • Previous thrombocytopenia (\<50 X 109/L) while using the current antithrombotic regimen.
  • Current diagnosis of heparin induced thrombocytopenia (HIT) or thrombotic thrombocytopenia purpura (TTP)

Key Trial Info

Start Date :

March 20 2018

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

December 31 2021

Estimated Enrollment :

300 Patients enrolled

Trial Details

Trial ID

NCT03288441

Start Date

March 20 2018

End Date

December 31 2021

Last Update

September 17 2020

Active Locations (21)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 6 (21 locations)

1

Oregon Health & Science University Hospital

Portland, Oregon, United States, 97239

2

Rambam Health Care Campus

Haifa, Israel

3

Meir Medical Center

Kfar Saba, Israel, 4428164

4

Rabin Medical Center

Petah Tikva, Israel